Evidence map›Paper›PMID 36438199›Full record

ArticleJournal of immunology research2022

Suppression of T-Cell Proliferation by Normal Density Granulocytes Led to CD183 Downregulation and Cytokine Inhibition in T-Cells.

Julia Westerlund, Sandra Askman, Åsa Pettersson, Thomas Hellmark, Åsa C M Johansson, Markus Hansson

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Julia WesterlundLund University, Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, BMC B13, 22184 Lund, Sweden.ORCID https://orcid.org/0000-0001-8578-4876
Sandra AskmanLund University, Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, BMC B13, 22184 Lund, Sweden.ORCID https://orcid.org/0000-0003-2997-4792
Åsa PetterssonLund University, Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, BMC B13, 22184 Lund, Sweden.ORCID https://orcid.org/0000-0002-5701-5380
Thomas HellmarkLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Nephrology, Barngatan 2, 22185 Lund, Sweden.ORCID https://orcid.org/0000-0002-2952-1155
Åsa C M JohanssonLund University, Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, BMC B13, 22184 Lund, Sweden.ORCID https://orcid.org/0000-0003-4800-9365
Markus HanssonSkåne University Hospital, Department of Hematology, Oncology and Radiation Physics, 22185 Lund, Sweden.ORCID https://orcid.org/0000-0002-7715-4548
Lund University · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Normal density granulocytes (NDGs) can suppress T-cell responses in a similar way as myeloid-derived suppressor cells (MDSCs). In this study, we tested the hypothesis that NDGs from healthy donors preferentially inhibit T helper 1 (Th1) cells and investigated the myeloid-derived suppressive effect in different T-cell populations. We found that NDG-induced suppression of T-cell proliferation was contact dependent, mediated by integrin CD11b, and dependent on NDG-production of reactive oxygen species (ROS). The suppression was rapid and occurred within the first few hours of coculture. The suppression did not influence the CD8

Indexed as

CytokinesLymphocyte ActivationCell ProliferationDown-RegulationGranulocytesCytokines

Identifiers

PMID36438199
PMCPMC9683987
OpenAlexW4309323745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.